Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon

E. A. El-Gabry; S. E. Strup; L. G. Gomella

Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon

E. A. El-Gabry, S. E. Strup, L. G. Gomella

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.

Original language	English
Pages (from-to)	221-222
Number of pages	2
Journal	Techniques in Urology
Volume	6
Issue number	3
State	Published - 2000

Keywords

Bicalutamide
PSA
Prostate cancer

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{e25c9545b9fc422e8e862879813820f3,

title = "Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon",

abstract = "Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.",

keywords = "Bicalutamide, PSA, Prostate cancer",

author = "El-Gabry, {E. A.} and Strup, {S. E.} and Gomella, {L. G.}",

year = "2000",

language = "English",

volume = "6",

pages = "221--222",

number = "3",

}

TY - JOUR

T1 - Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon

AU - El-Gabry, E. A.

AU - Strup, S. E.

AU - Gomella, L. G.

PY - 2000

Y1 - 2000

N2 - Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.

AB - Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.

KW - Bicalutamide

KW - PSA

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0033895511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033895511&partnerID=8YFLogxK

M3 - Article

C2 - 10963494

AN - SCOPUS:0033895511

SN - 1079-3259

VL - 6

SP - 221

EP - 222

JO - Techniques in Urology

JF - Techniques in Urology

IS - 3

ER -

Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this